×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
中国医学科学院 北... [85]
复旦大学上海医学院 [14]
中南大学 [7]
西安交通大学 [6]
吉林大学白求恩第一医... [3]
大连理工大学 [2]
更多...
内容类型
期刊论文 [108]
会议论文 [23]
发表日期
2023 [1]
2020 [1]
2019 [19]
2018 [17]
2017 [25]
2016 [9]
更多...
学科主题
材料科学与物理化学 [1]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共131条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Results of the phase IIa study to evaluate the efficacy and safety of rezivertinib (BPI-7711) for the first-line treatment of locally advanced or metastatic EGFR mutation from a phase I
期刊论文
BMC MEDICINE, 2023, 卷号: 21, 期号: 1
作者:
Yuankai Shi
;
Jianying Zhou
;
Yanqiu Zhao
;
Bo Zhu
;
Liangming Zhang
收藏
  |  
浏览/下载:0/0
  |  
提交时间:2024/05/07
Safety, Clinical Activity, and Pharmacokinetics of Al flutinib (AST2818) in Patients With Advanced NSCLC With EGFR T790M Mutation
期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2020, 卷号: 15, 期号: 6, 页码: 1015-1026
作者:
Shi, Yuankai
;
Zhang, Shucai
;
Hu, Xingsheng
;
Feng, Jifeng
;
Ma, Zhiyong
收藏
  |  
浏览/下载:38/0
  |  
提交时间:2020/12/24
Alflutinib
NSCLC
EGFR T790M mutation
Efficacy
Safety
Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trial
期刊论文
LANCET HAEMATOLOGY, 2019, 卷号: 6, 期号: 1
作者:
Zhang, Wei
;
Gao, Yuhuan
;
Jin, Zhengming
;
Zhou, Jianfeng
;
Jin, Chuan
收藏
  |  
浏览/下载:46/0
  |  
提交时间:2019/12/05
Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial
期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2019, 卷号: 14, 期号: 5
作者:
Wu, Yi-Long
;
Lu, Shun
;
Cheng, Ying
;
Zhou, Caicun
;
Wang, Jie
收藏
  |  
浏览/下载:29/0
  |  
提交时间:2019/12/05
Chinese population
Nivolumab
NSCLC
Phase III clinical study
VTE Risk Profiles and Prophylaxis in Medical and Surgical Inpatients The Identification of Chinese Hospitalized Patients' Risk Profile for Venous Thromboembolism (DissolVE-2)-A Cross-sectional Study
期刊论文
CHEST, 2019, 卷号: 155, 期号: 1
作者:
Zhai, Zhenguo
;
Kan, Quancheng
;
Li, Weimin
;
Qin, Xinyu
;
Qu, Jieming
收藏
  |  
浏览/下载:61/0
  |  
提交时间:2019/12/05
China
prophylaxis
risk profile
VTE
VTE Risk Profiles and Prophylaxis in Medical and Surgical Inpatients The Identification of Chinese Hospitalized Patients' Risk Profile for Venous Thromboembolism (DissolVE-2)-A Cross-sectional Study
期刊论文
CHEST, 2019, 卷号: 155, 页码: 114-122
作者:
Zhai, Zhenguo
;
Kan, Quancheng
;
Li, Weimin
;
Qin, Xinyu
;
Qu, Jieming
收藏
  |  
浏览/下载:61/0
  |  
提交时间:2019/11/19
VTE
prophylaxis
China
risk profile
Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced Non-Small Cell Lung Cancer: CheckMate 078 Randomized Phase III Clinical Trial
期刊论文
Journal of Thoracic Oncology, 2019
作者:
Yi-Long Wu
;
Shun Lu
;
Ying Cheng
;
Caicun Zhou
;
Jie Wang
收藏
  |  
浏览/下载:15/0
  |  
提交时间:2019/02/25
Chinese
population
nivolumab
non-small
cell
lung
cancer
phase
III
clinical
study
Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma : a multicentre, single-arm, phase 2 trial
期刊论文
The Lancet Haematology, 2019, 卷号: Vol.6 No.1, 页码: e12-e19
作者:
Yuankai Shi
;
Hang Su
;
Yongping Song
;
Wenqi Jiang
;
Xiuhua Sun
收藏
  |  
浏览/下载:39/0
  |  
提交时间:2019/02/25
VTE Risk Profiles and Prophylaxis in Medical and Surgical Inpatients The Identification of Chinese Hospitalized Patients' Risk Profile for Venous Thromboembolism -A Cross-sectional Study
期刊论文
CHEST, 2019, 卷号: Vol.155 No.1, 页码: 114-122
作者:
Zhai, Zhenguo
;
Kan, Quancheng
;
Li, Weimin
;
Qin, Xinyu
;
Qu, Jieming
收藏
  |  
浏览/下载:54/0
  |  
提交时间:2019/12/13
VTE
prophylaxis
China
risk profile
Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trial
期刊论文
LANCET HAEMATOLOGY, 2019, 卷号: 6, 期号: 1, 页码: E12-E19
作者:
Shi, Yuankai
;
Su, Hang
;
Song, Yongping
;
Jiang, Wenqi
;
Sun, Xiuhua
收藏
  |  
浏览/下载:17/0
  |  
提交时间:2019/12/11
©版权所有 ©2017 CSpace - Powered by
CSpace